GE Healthcare Japan Launches Invenia ABUS Premium Breast Ultrasound System

GE Healthcare Japan Unveils the New Invenia ABUS Premium

On March 23, 2026, GE Healthcare Japan announced the launch of its cutting-edge breast ultrasound imaging device, the Invenia ABUS Premium. This system, developed to tackle the ongoing challenges in medical care, is the latest iteration of the Invenia ABUS line, which originally debuted in Japan back in 2014. The Invenia ABUS Premium incorporates artificial intelligence technology for the first time, enhancing its capabilities significantly while improving hardware and probe efficiency.

Key Features of Invenia ABUS Premium

1. Faster and Smoother Workflow
The new AI-enhanced features automatically detect the position of the nipple during examinations, visually displaying aspects such as the quality and coverage of the scanned volume data. This automation reduces tasks for healthcare professionals, leading to a more seamless examination process. Moreover, hardware updates have resulted in scanning speeds that are approximately 40% faster compared to previous models, thereby reducing examination times. It should be noted that while the device’s capabilities will be available post-market adoption, their effectiveness is subject to user discretion.

2. Enhanced Imaging Quality
The Invenia ABUS Premium features a redesigned probe that better fits the breast, facilitating a wider frequency bandwidth that improves spatial and contrast resolution. Enhanced signal processing ensures focus across all pixels, yielding more uniform images. Notably, images captured with this premium model show significant improvement, particularly around the nipple area.

3. Flexible Interpretation Options
Users can install dedicated analysis software on their PCs for reading the scan data, allowing flexibility for interpretations whether on-site or remotely. Additionally, with the introduction of a wireless adapter, data can be transferred smoothly without the hassle of cables, thus improving operational efficiency.

4. Mobile Breast Screening Capabilities
The Invenia ABUS Premium includes a specialized vehicle mounting system, enabling safe transportation of the equipment. This enhancement allows the device to be employed in field examinations, contributing to mobile screening solutions in community healthcare settings.

Addressing the Increasing Need for Breast Cancer Screening

As breast cancer incidence rates rise, the necessity for effective breast ultrasound screening becomes increasingly critical. Traditional ultrasound examinations often depend heavily on the operator's experience and skill, leading to variabilities in quality and extended examination durations. GE Healthcare aims to address these operational challenges with the Invenia ABUS Premium, striving to offer breast ultrasound to a broader audience and enhance accessibility to essential screening services.

About GE Healthcare Japan

Founded in 1982, GE Healthcare Japan serves as a vital hub within GE Healthcare, focusing on the full spectrum of patient care—from prevention and diagnosis to treatment and ongoing monitoring. The company is dedicated to developing intelligent devices and data analysis capabilities that meet local healthcare needs. With approximately 1,500 employees and comprehensive operations from R&D to service across Japan, GE Healthcare continues its commitment to resolving the pressing challenges faced by the healthcare sector. For more information, please visit www.gehealthcare.com.